Live revision! Join us for our free exam revision livestreams Watch now

In the News

GSK hit by fine for anti-competitive behaviour

Graham Watson

12th February 2016

Quelle surprise - on being fined for anti-competitive behaviour, GSK deny the allegations and argue that they brought the drugs of their generic rivals to the market earlier, saving the NHS money. Quite why a profit-maximising firm would act in this fashion, I don't know but I'm smelling a rat not least because "the CMA pointed out that after generic paroxetine entered the market properly at the end of 2013, average prices for the drug fell more than 70% in two years. More here from the CMA website.

Graham Watson

Graham Watson has taught Economics for over twenty years. He contributes to Tutor2U, reads voraciously and is interested in all aspects of Teaching and Learning.

© 2002-2024 Tutor2u Limited. Company Reg no: 04489574. VAT reg no 816865400.